Sarepta
SRPT
Sarepta (SRPT) news
Recent news
Sarepta Therapeutics appoints Michael Severino CEO
AInvest Wire · Jul 27, 2026Sarepta Therapeutics appoints Michael Severino, M.D., chief executive officer
AInvest Wire · Jul 27, 2026Sarepta Therapeutics to announce second quarter 2026 financial results
AInvest Wire · Jul 22, 2026Sarepta Therapeutics announces inducement grants under Nasdaq listing Rule 5635(c)(4)
AInvest Wire · Jun 30, 2026Sarepta reports FDA accepts SNDAs for Amondys 45, Vyondys 53
AInvest Wire · Jun 30, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.